Cardio Diagnostics Holdings Inc
CDIO1.290USD
+0.240+22.86%
Fechamento 02/06, 16:00（ET）Cotações atrasadas em 15 min
2.28MValor de mercado
PerdaP/L TTM
Mais detalhes de Cardio Diagnostics Holdings Inc Empresa
Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development, and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.
Informações de Cardio Diagnostics Holdings Inc
Código da empresaCDIO
Nome da EmpresaCardio Diagnostics Holdings Inc
Data de listagemNov 23, 2021
CEODogan (Meeshanthini V)
Número de funcionários13
Tipo de títulosOrdinary Share
Fim do ano fiscalNov 23
Endereço311 W. Superior Street
CidadeCHICAGO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal60645
Telefone18552269991
Site
Código da empresaCDIO
Data de listagemNov 23, 2021
CEODogan (Meeshanthini V)
Executivos da empresa Cardio Diagnostics Holdings Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
4.28K
--
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
3.87K
+1.00%
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
3.25K
+1.00%
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
2.39K
--
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Paul F. Burton, J.D.
Mr. Paul F. Burton, J.D.
Independent Director
Independent Director
--
--
Ms. Wendy J. Betts
Ms. Wendy J. Betts
Independent Director
Independent Director
--
--
Mr. Peter K. Fung
Mr. Peter K. Fung
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
4.28K
--
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
3.87K
+1.00%
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
3.25K
+1.00%
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
2.39K
--
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Detalhamento da receita
Os dados relevantes ainda não foram divulgados pela empresa.
Os dados relevantes ainda não foram divulgados pela empresa.
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.
Distribuição de ações
Atualizado em: sáb, 31 de jan
Atualizado em: sáb, 31 de jan
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Dogan (Meeshanthini)
3.02%
Bd Holding, Inc
2.90%
BlackRock Institutional Trust Company, N.A.
1.95%
The Vanguard Group, Inc.
1.32%
Citadel Advisors LLC
1.07%
Outro
89.74%
Investidores
Investidores
Proporção
Dogan (Meeshanthini)
3.02%
Bd Holding, Inc
2.90%
BlackRock Institutional Trust Company, N.A.
1.95%
The Vanguard Group, Inc.
1.32%
Citadel Advisors LLC
1.07%
Outro
89.74%
Tipos de investidores
Investidores
Proporção
Investment Advisor
4.40%
Individual Investor
3.90%
Corporation
2.90%
Hedge Fund
1.12%
Investment Advisor/Hedge Fund
0.83%
Outro
86.86%
Participação acionária institucional
Atualizado em: seg, 8 de dez
Atualizado em: seg, 8 de dez
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
39
115.09K
6.22%
--
2025Q3
41
115.09K
6.70%
+30.25K
2025Q2
39
84.84K
5.90%
+274.00
2025Q1
35
84.57K
5.41%
-9.47K
2024Q4
39
85.72K
5.08%
+29.79K
2024Q3
59
55.93K
19.52%
-4.45K
2024Q2
61
60.37K
27.33%
+6.29K
2024Q1
58
54.08K
29.21%
-151.37K
2023Q4
58
55.21K
23.41%
+40.18K
2023Q3
53
15.03K
36.07%
+2.55K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Dogan (Meeshanthini)
55.18K
3.02%
--
--
Aug 25, 2025
Bd Holding, Inc
52.88K
2.9%
--
--
Aug 25, 2025
BlackRock Institutional Trust Company, N.A.
35.57K
1.95%
--
--
Sep 30, 2025
The Vanguard Group, Inc.
24.12K
1.32%
+11.44K
+90.22%
Sep 30, 2025
Citadel Advisors LLC
19.52K
1.07%
+19.52K
--
Sep 30, 2025
DRW Securities, LLC
18.16K
0.99%
+18.16K
--
Sep 30, 2025
Geode Capital Management, L.L.C.
15.10K
0.83%
+1.73K
+12.97%
Sep 30, 2025
Dogan (Timur)
4.28K
0.23%
--
--
Aug 25, 2025
Hosseinion (Warren)
3.87K
0.21%
+1.00
+0.03%
Aug 25, 2025
Philibert (Robert)
3.25K
0.18%
+1.00
+0.03%
Aug 25, 2025
Ver Mais
ETFs Relacionados
Nome
Proporção
Sem dados
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Data ex-dividendo
Tipo
Proporção
May 08, 2025
Merger
30→1
Data
Data ex-dividendo
Tipo
Proporção
May 08, 2025
Merger
30→1
